In 2023, the Multinational Association of Supportive Care in Cancer (MASCC) and the European Society for Medical Oncology (ESMO) updated their guideline on the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. This specialist Guidelines overview for secondary care oncologists covers the latest recommendations for preventing these adverse effects in cancer patients.